prikaz prve stranice dokumenta Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review
  Preuzmi
PDF 668.27 KB
Znanstveni rad - Pregledni rad
Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review
Journal of Clinical Medicine, 12 (2023), 15; 4953. https://doi.org/10.3390/jcm12154953
Etrusco, Andrea; Laganà, Antonio; Chiantera, Vito; Vitagliano, Amerigo; Cicinelli, Ettore; Mikuš, Mislav; Šprem Goldštajn, Marina; Ferrari, Federico; Uccella, Stefano; Garzon, Simone; Gerli, Sandro; Favilli, Alessandro

Citirajte ovaj rad

Etrusco, A., Laganà, A., Chiantera, V., Vitagliano, A., Cicinelli, E., Mikuš, M. ... Favilli, A. (2023). Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review. Journal of Clinical Medicine, 12. (15). doi: 10.3390/jcm12154953

Etrusco, Andrea, et al. "Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review." Journal of Clinical Medicine, vol. 12, br. 15, 2023. https://doi.org/10.3390/jcm12154953

Etrusco, Andrea, Antonio Laganà, Vito Chiantera, Amerigo Vitagliano, Ettore Cicinelli, Mislav Mikuš, Marina Šprem Goldštajn, et al. "Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review." Journal of Clinical Medicine 12, br. 15 (2023). https://doi.org/10.3390/jcm12154953

Etrusco, A., et al. (2023) 'Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review', Journal of Clinical Medicine, 12(15). doi: 10.3390/jcm12154953

Etrusco A, Laganà A, Chiantera V, Vitagliano A, Cicinelli E, Mikuš M, i sur.. Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review. Journal of Clinical Medicine [Internet]. 27.07.2023. [pristupljeno 29.11.2024.];12(15). doi: 10.3390/jcm12154953

A. Etrusco, et al., "Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review", Journal of Clinical Medicine, vol. 12, br. 15, Srpanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:734263. [Citirano: 29.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:734263
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Feasibility and Surgical Outcomes of Hysteroscopic Myomectomy of FIGO Type 3 Myoma: A Systematic Review
AutorAndrea Etrusco
AutorAntonio Laganà
AutorVito Chiantera
AutorAmerigo Vitagliano
AutorEttore Cicinelli
AutorMislav Mikuš
AutorMarina Šprem Goldštajn
AutorFederico Ferrari
AutorStefano Uccella
AutorSimone Garzon
AutorSandro Gerli
AutorAlessandro Favilli
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA GINEKOLOGIJU I OPSTETRICIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Ginekologija i opstetricija
Sažetak (engleski)
The latest classification from the Fédération Internationale de Gynécologie et d’Obstétrique (FIGO) has reclassified type 3 myomas, changing their classification from intramural to submucosal. While hysteroscopic myomectomy is considered the gold standard treatment for patients experiencing symptoms from submucosal myomas, there are currently no specific guidelines available for managing type 3 myomas, and the optimal surgical approach remains uncertain. Methods: The search for suitable articles published in English was carried out using the following databases (PROSPERO ID CRD42023418602): MEDLINE, EMBASE, Global Health, The Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register), Health Technology Assessment Database, Web of Science and search register. Only original studies reporting data on hysteroscopic myomectomy of type 3 myoma were considered eligible. The main outcomes investigated were the effectiveness and feasibility of hysteroscopic myomectomy and reproductive outcomes after surgical treatment. Results: Two hundred and sixty-one studies were screened and nineteen of these were read for eligibility. Three studies encompassing 56 patients in total were included. Among the overall population studied, three patients needed an additional procedure to completely remove the myoma and five cases of post-surgical synechiae were recorded. No complications were reported. Of 42 patients wishing for pregnancy, the cumulative live birth rates before and after the hysteroscopic myomectomy were 14.3% and 42.9%, respectively. Conclusions: Hysteroscopic myomectomy appears to be a safe and feasible approach. Nevertheless, data reported in the literature are extremely scarce and based on studies with few patients enrolled. New evidence is needed to assess the safety and effectiveness of hysteroscopic treatment for FIGO type 3 myomas.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of Clinical Medicine
Brojčani podacivol. 12, br. 15, 4953
e-ISSN2077-0383
DOIhttps://doi.org/10.3390/jcm12154953
URN:NBNurn:nbn:hr:105:734263
Datum objave publikacije2023-07-27
URL dokumentahttps://www.mdpi.com/2077-0383/12/15/4953
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-09-02 08:14:59